CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. Xu S, Shiomi H, Yamashita Y, Koyama S, et al. PLoS One 2024;19:e0297231.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu S, Shiomi H, Yamashita Y, Koyama S, et al. CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PLoS One 2024;19:e0297231.
PMID: 38507394